James D. Clelland

916 total citations
29 papers, 666 citations indexed

About

James D. Clelland is a scholar working on Molecular Biology, Clinical Biochemistry and Neurology. According to data from OpenAlex, James D. Clelland has authored 29 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Clinical Biochemistry and 5 papers in Neurology. Recurrent topics in James D. Clelland's work include Metabolism and Genetic Disorders (5 papers), Amino Acid Enzymes and Metabolism (4 papers) and Tryptophan and brain disorders (3 papers). James D. Clelland is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Amino Acid Enzymes and Metabolism (4 papers) and Tryptophan and brain disorders (3 papers). James D. Clelland collaborates with scholars based in United States, United Kingdom and Spain. James D. Clelland's co-authors include Laura L. Read, Catherine L. Clelland, Paul J. Thornalley, R. Surtees, Mary Richardson, Fumio Matsumura, Josephine C. Adams, Shigeko Yamashiro, I M Hann and Helen M. Chao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

James D. Clelland

29 papers receiving 646 citations

Peers

Countries citing papers authored by James D. Clelland

Since Specialization

Citations

This map shows the geographic impact of James D. Clelland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Clelland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Clelland more than expected).

Fields of papers citing papers by James D. Clelland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Clelland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Clelland. The network helps show where James D. Clelland may publish in the future.

Co-authorship network of co-authors of James D. Clelland

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Clelland. A scholar is included among the top collaborators of James D. Clelland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Clelland. James D. Clelland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The relationship between COMT, proline, and negative symptoms in clinical high risk and recent psychosis onset 2024 ·Translational Psychiatry ·James D. Clelland, (unknown), (unknown), Julia Anderson, (unknown), Ragy R. Girgis, Catherine L. Clelland	2
2	Warning: Artificial intelligence chatbots can generate inaccurate medical and scientific information and references 2024 ·SHILAP Revista de lepidopterología ·Catherine L. Clelland, Stuart Moss, James D. Clelland	4
3	Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort 2021 ·BJPsych Open ·Catherine L. Clelland, (unknown), (unknown), James D. Clelland	31
4	Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders 2018 ·Psychiatry Research ·James D. Clelland, Laura L. Read, (unknown), Catherine L. Clelland	7
5	Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder 2016 ·Translational Psychiatry ·Catherine L. Clelland, Valérie Drouet, Kelly C. Rilett, (unknown), (unknown), (unknown), Laura L. Read, James D. Clelland	21
6	Vitamin D insufficiency and schizophrenia risk: Evaluation of hyperprolinemia as a mediator of association 2014 ·Schizophrenia Research ·James D. Clelland, Laura L. Read, Valérie Drouet, (unknown), (unknown), Karen Duff, (unknown), (unknown), Catherine L. Clelland	26
7	Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile 2013 ·PLoS ONE ·Catherine L. Clelland, Laura L. Read, (unknown), (unknown), Carter Bancroft, James D. Clelland	25
8	Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome 2011 ·Schizophrenia Research ·Catherine L. Clelland, Laura L. Read, Amanda N. Baraldi, (unknown), (unknown), (unknown), (unknown), James D. Clelland	52
9	Investigation of the phenylalanine hydroxylase gene and tardive dyskinesia 2006 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Mary Richardson, Helen M. Chao, Laura L. Read, James D. Clelland, Raymond F. Suckow	3
10	Analysis of Plasma Biopterin Levels in Psychiatric Disorders Suggests a Common BH4 Deficit in Schizophrenia and Schizoaffective Disorder 2006 ·Neurochemical Research ·Mary Richardson, Laura L. Read, Margaret A. Reilly, James D. Clelland, Catherine L. Clelland	40
11	Evidence for a Tetrahydrobiopterin Deficit in Schizophrenia 2005 ·Neuropsychobiology ·Mary Richardson, Laura L. Read, Catherine L. Clelland, Margaret A. Reilly, Helen M. Chao, Robert W. Guynn, Raymond F. Suckow, James D. Clelland	33
12	Phenylalanine hydroxylase gene in psychiatric patients: screening and functional assay of mutations 2003 ·Biological Psychiatry ·Mary Richardson, Laura L. Read, James D. Clelland, Helen M. Chao, Margaret A. Reilly, Anne Romstad, Raymond F. Suckow	15
13	Efficacy of the Branched-Chain Amino Acids in the Treatment of Tardive Dyskinesia in Men 2003 ·American Journal of Psychiatry ·Mary Richardson, Margaret Bevans, Laura L. Read, Helen M. Chao, James D. Clelland, Raymond F. Suckow, Timothy J. Maher, Leslie Citrome	41
14	Cell-Matrix Adhesions Differentially Regulate Fascin Phosphorylation 1999 ·Molecular Biology of the Cell ·Josephine C. Adams, James D. Clelland, (unknown), Fumio Matsumura, Shigeko Yamashiro, (unknown)	112
15	Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies. 1998 ·Journal of Clinical Oncology ·R. Surtees, James D. Clelland, I M Hann	54
16	Cerebrospinal fluid concentrations of nitrate plus nitrite during the treatment of acute lymphoblastic leukaemia in childhood 1998 ·Leukemia Research ·R. Surtees, James D. Clelland, Simon Heales	5
17	Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring 1998 ·Thorax ·(unknown), George Chalmers, James D. Clelland, Rajan Madhok, Andrew J. Peacock	45
18	Characteristics of the inhibition of human promyelocytic leukaemia HL60 cell growth by S-d-lactoylglutathione in vitro 1993 ·Leukemia Research ·Linda Edwards, James D. Clelland, Paul J. Thornalley	10
19	Inhibition of growth of human leukaemia 60 cells by S-2-hydroxyacylglutathiones and monoethyl ester derivatives 1992 ·Biochemical Pharmacology ·James D. Clelland, (unknown), Paul J. Thornalley	16
20	Synthesis of ¹⁴C‐labelled methylglyoxal and S‐D‐lactoylglutathione 1990 ·Journal of Labelled Compounds and Radiopharmaceuticals ·James D. Clelland, Paul J. Thornalley	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact